Geo News
Community curated by people like you
LatestAICryptoHealthWorld AffairsUS Politics

Asthma stories

Oct 2, 2026

TTHealthWatch podcast covers new treatment target for asthma and COPD

The weekly podcast from Texas Tech University features discussion of a new therapeutic target for asthma and chronic obstructive pulmonary disease, along with other top medical stories. The podcast is co-hosted by Elizabeth Tracey of Johns Hopkins Medicine and Dr. Rick Lange of Texas Tech Health El Paso.

Oct 2, 2026·3 sources
00

Top claims

  • ▪The purinergic 2X3 receptor antagonists gefapixant, BLU-5937, and sivopixant (S-600918) are targeted therapies under development for refractory chronic cough.
  • ▪A phase I trial evaluated ARO-RAGE, an inhaled, targeted, small interfering RNA therapy that targets the receptor for advanced glycation end products (RAGE) in pulmonary inflammation.
  • ▪Kenney Blewett's pulmonologist prescribed a new chronic obstructive pulmonary disease medication on June 2, 2026, which Walgreens delayed due to an insurance issue.

Subtopics

COPD1Medical research1Respiratory diseases1

Related timelines

Russia-Ukraine war

136 stories

Iran War

209 stories

Payments

118 stories

Trump administration

116 stories

AI Data Center Gold Rush

105 stories